Rellim Capital Management

Rellim Capital Management is a family investment firm based in Glenview, Illinois, dedicated to creating value across generations. Operating as a family office, the firm employs a diversified investment strategy, actively seeking new opportunities to deploy capital. Their approach often involves co-investing alongside other established venture capital and private equity firms, indicating a collaborative and strategic engagement in the investment landscape.

The firm's investment activities span various sectors, with a notable participation in the biotechnology and life sciences industry. For instance, Rellim Capital Management was an investor in the Series A funding round for Orbital Therapeutics in April 2023. This significant investment was part of a larger $270 million round, demonstrating the firm's capacity to engage in substantial deals within innovative and high-growth sectors.

While specific details regarding the firm's founding and individual team members are not extensively publicized, its designation as a family investment firm underscores a commitment to long-term value creation and a generational perspective on wealth management. The firm's headquarters are located at 2101 Claire Court, Glenview, IL 60025, United States.